Over 50 Years of Specialty Injectables
American Regent develops, manufactures and supplies high-quality sterile injectables for healthcare providers and their patients.
Dedicated to Alleviating Drug Shortages
We are committed to collaborating with the FDA to prevent or mitigate drug shortages that impact the health of patients.
Check Product Availability
Updated August 13, 2022
HydrALAZINE Hydrochloride
- 20 mg/mL | 1 mL Single Dose Vial
- Shelf Pack — 25
Papaverine HCL
- 30 mg/mL | 2 mL Single Dose Vial
- Shelf Pack — 25
Zinc Sulfate
- 5 mg/mL | 5 mL Pharmacy Bulk Package Vial
- Shelf Pack — 25
News Center
American Regent Launches a New Vial Presentation of ProvayBlue® (methylene blue) Injection, USP
Melville, NY – June 28, 2022: American Regent, Inc. and Provepharm Life Solutions are pleased to announce the availability of ProvayBlue® (methylene blue) Injection, USP in a 10 mL single-dose vial.
American Regent announces the launch of Selenious Acid Injection, USP in 12 mcg/2 mL single-dose vial.
Melville, NY – March 31, 2022: American Regent, Inc. is pleased to announce the launch of Selenious Acid Injection, USP in a new concentration and vial size.
American Regent introduces FDA-approved Vasopressin Injection, USP
Melville, NY – February 3, 2022: American Regent announces the introduction and availability of FDA-approved Vasopressin Injection, USP. Vasopressin is indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines.